of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (DART)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00925717
First received: June 19, 2009
Last updated: January 25, 2010
Last verified: January 2010

June 19, 2009
January 25, 2010
May 2009
Not Provided
Investigate LDL-C goal achievement rate according to ADA recommendation [ Time Frame: Within the last 6 months from the date of data entry. ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00925717 on ClinicalTrials.gov Archive Site
Investigate reduction of 10-year risk for CHD by using UKPDS risk engine [ Time Frame: Within the last 6 months from the date of data entry. ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months.

Low Density Lipoprotein Cholesterol Goal Achievement
Not Provided
2500 patients
Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4045
October 2009
Not Provided

Inclusion Criteria:

  • Subjects who was diagnosed as diabetes
  • Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
  • Clinic visit in the past 6 months more than once

Exclusion Criteria:

  • Subjects who are unwilling or unable to provide their examination and lab result of medical chart.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT00925717
NIS-CKR-DUM-2009/1
No
Hyunah Caroline, Choi / CV TA Physician, AstraZeneca Pharmaceuticals
AstraZeneca
Not Provided
Study Director: MoonGyu Lee, Ph.D. Samsung Medical Center
AstraZeneca
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP